These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 37633425)

  • 1. Clinical Characteristics of and Risk Factors for Subsequent Carbapenemase-producing Enterobacterales (CPE) Bacteraemia in Rectal CPE Carriers.
    Kang SW; Park S; Kim AR; Han J; Lee J; Seo H; Sung H; Kim MN; Chang E; Bae S; Jung J; Kim MJ; Kim SH; Lee SO; Choi SH; Kim YS; Song EH; Chong YP
    Int J Antimicrob Agents; 2023 Nov; 62(5):106959. PubMed ID: 37633425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dynamics of carbapenemase-producing Enterobacterales intestinal colonisation in the elderly population after hospital discharge, Italy, 2018-2020.
    Tinelli M; Rossini A; Scudeller L; Zabzuni D; Errico G; Fogato E; D'Angelo R; Gentiloni Silverj F; Cesana E; Bergamaschini LC; Pasi F; Monaco M; Cerquetti M; Pantosti A; Giufrè M
    Int J Antimicrob Agents; 2022 Jun; 59(6):106594. PubMed ID: 35483624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors for acquisition of carbapenemase-producing versus non-carbapenemase-producing enterobacterales: a case-control study.
    Hassoun-Kheir N; Hussein K; Karram M; Saffuri M; Badaan S; Peleg S; de Kraker MEA; Aboelhega W; Warman S; Alon T; Eluk O; Geffen Y; Paul M
    Clin Microbiol Infect; 2023 May; 29(5):629-634. PubMed ID: 36641053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and Demographic Characteristics of Patients With a New Diagnosis of Carriage or Clinical Infection With Carbapenemase-Producing
    Adar A; Zayyad H; Azrad M; Libai K; Aharon I; Nitzan O; Peretz A
    Front Public Health; 2021; 9():616793. PubMed ID: 33614584
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical and epidemiological features of patients colonised by different types of carbapenemase-producing Enterobacterales.
    Assis R; Lasnoy M; Adler A
    J Glob Antimicrob Resist; 2021 Sep; 26():108-113. PubMed ID: 34118482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiology and risk factors of rectal colonization of carbapenemase-producing Enterobacteriaceae among high-risk patients from ICU and HSCT wards in a university hospital.
    Yan L; Sun J; Xu X; Huang S
    Antimicrob Resist Infect Control; 2020 Sep; 9(1):155. PubMed ID: 32967718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence and Time-to-Onset of Carbapenemase-Producing Enterobacterales (CPE) Infections in CPE Carriers: a Retrospective Cohort Study.
    Hoellinger B; Deboscker S; Danion F; Lavigne T; Severac F; Ruch Y; Ursenbach A; Lefebvre N; Boyer P; Hansmann Y
    Microbiol Spectr; 2022 Dec; 10(6):e0186822. PubMed ID: 36321906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genomic and clinical characterisation of multidrug-resistant carbapenemase-producing ST231 and ST16 Klebsiella pneumoniae isolates colonising patients at Siriraj hospital, Bangkok, Thailand from 2015 to 2017.
    Boonyasiri A; Jauneikaite E; Brinkac LM; Greco C; Lerdlamyong K; Tangkoskul T; Nguyen K; Thamlikitkul V; Fouts DE
    BMC Infect Dis; 2021 Feb; 21(1):142. PubMed ID: 33541274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiology of carbapenem-resistant and carbapenemase-producing Enterobacterales in the Netherlands 2017-2019.
    Wielders CCH; Schouls LM; Woudt SHS; Notermans DW; Hendrickx APA; Bakker J; Kuijper EJ; Schoffelen AF; de Greeff SC; ;
    Antimicrob Resist Infect Control; 2022 Apr; 11(1):57. PubMed ID: 35397546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between rectal colonisation by Klebsiella pneumoniae carbapenemase-producing K. pneumoniae and mortality: a prospective, observational study.
    Cano Á; Gutiérrez-Gutiérrez B; Machuca I; Torre-Giménez J; Frutos-Adame A; García-Gutiérrez M; Gallo-Marín M; Gracia-Ahufinger I; Artacho MJ; Natera AM; Pérez-Nadales E; Castón JJ; Mameli S; Gómez-Delgado F; de la Fuente C; Salcedo I; Rodríguez-Baño J; Martínez-Martínez L; Torre-Cisneros J
    J Glob Antimicrob Resist; 2022 Jun; 29():476-482. PubMed ID: 34788693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Israeli national policy for discontinuation of isolation of carbapenem-resistant Enterobacterales carriers by carbapenemase type: a retrospective cohort study.
    Dickstein Y; Solter E; Schwartz D; Nutman A; Harevrich I; Wulffhart L; Carmeli Y; Schwaber MJ
    Clin Microbiol Infect; 2021 Oct; 27(10):1518.e1-1518.e3. PubMed ID: 34111587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparing mortality in patients with carbapenemase-producing carbapenem resistant Enterobacterales and non-carbapenemase-producing carbapenem resistant Enterobacterales bacteremia.
    Hovan MR; Narayanan N; Cedarbaum V; Bhowmick T; Kirn TJ
    Diagn Microbiol Infect Dis; 2021 Dec; 101(4):115505. PubMed ID: 34399381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early OXA-48-Producing
    Gijón D; Tedim AP; Valverde A; Rodríguez I; Morosini MI; Coque TM; Manrique M; Pareja E; Tobes R; Ruiz-Garbajosa P; Cantón R
    mSphere; 2020 Apr; 5(2):. PubMed ID: 32269151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacodynamic evaluation of meropenem, cefepime, or aztreonam combined with a novel β-lactamase inhibitor, nacubactam, against carbapenem-resistant and/or carbapenemase-producing Klebsiella pneumoniae and Escherichia coli using a murine thigh-infection model.
    Hagihara M; Kato H; Sugano T; Okade H; Sato N; Shibata Y; Sakanashi D; Asai N; Koizumi Y; Suematsu H; Yamagishi Y; Mikamo H
    Int J Antimicrob Agents; 2021 May; 57(5):106330. PubMed ID: 33789129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and molecular characteristics and risk factors for patients acquiring carbapenemase-producing and non-carbapenemase-producing carbapenem-nonsusceptible-Enterobacterales bacteremia.
    Wu AY; Chang H; Wang NY; Sun FJ; Liu CP
    J Microbiol Immunol Infect; 2022 Dec; 55(6 Pt 2):1229-1238. PubMed ID: 34824020
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systematic Analysis of Mobile Genetic Elements Mediating β-Lactamase Gene Amplification in Noncarbapenemase-Producing Carbapenem-Resistant
    Shropshire WC; Konovalova A; McDaneld P; Gohel M; Strope B; Sahasrabhojane P; Tran CN; Greenberg D; Kim J; Zhan X; Aitken S; Bhatti M; Savidge TC; Treangen TJ; Hanson BM; Arias CA; Shelburne SA
    mSystems; 2022 Oct; 7(5):e0047622. PubMed ID: 36036505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiology and clinical characteristics of infection/colonization due to carbapenemase-producing Enterobacterales in neonatal patients.
    Wang J; Lv Y; Yang W; Zhao P; Yin C
    BMC Microbiol; 2022 Jul; 22(1):177. PubMed ID: 35820815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carbapenemase-producing Enterobacterales causing secondary infections during the COVID-19 crisis at a New York City hospital.
    Gomez-Simmonds A; Annavajhala MK; McConville TH; Dietz DE; Shoucri SM; Laracy JC; Rozenberg FD; Nelson B; Greendyke WG; Furuya EY; Whittier S; Uhlemann AC
    J Antimicrob Chemother; 2021 Jan; 76(2):380-384. PubMed ID: 33202023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors for colonization by carbapenemase-producing enterobacteria at admission to a Surgical ICU: A retrospective study.
    Maseda E; Salgado P; Anillo V; Ruiz-Carrascoso G; Gómez-Gil R; Martín-Funke C; Gimenez MJ; Granizo JJ; Aguilar L; Gilsanz F
    Enferm Infecc Microbiol Clin; 2017; 35(6):333-337. PubMed ID: 27016135
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genotypic Distribution and Antimicrobial Susceptibilities of Carbapenemase-Producing
    Jeong S; Lee N; Park MJ; Jeon K; Kim HS; Kim HS; Kim JS; Song W
    Ann Lab Med; 2022 Jan; 42(1):36-46. PubMed ID: 34374347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.